Focus

Our main focus is on globalizing our development portfolio. Apart from products produced for the European, US and Canadian markets, we are intensively developing products for the emerging generic drug markets such as Japan, Australia, Brazil and Mexico. We are furthermore increasing the number of launches of already established products to new markets and are launching a growing number of new products, by endeavoring to continuously introduce new ones. Besides we are extending the list of patent applications, thus protecting innovative approaches to the synthesis of active pharmaceutical ingredients and to the development of finished pharmaceutical products.

By strengthening the global presence of our products, we are further contributing to the efficiency of development processes and reducing the development costs of individual projects.

Vertical integration remains our strategic advantage and orientation. A significant proportion of our new pharmaceutical products hence use an active pharmaceutical ingredient that we developed ourselves.